PyInvesting

Market research

JNJ.F Johnson & Johnson

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
567B
P/E ratio
31.88
Analyst target
Not available
Dividend yield
2.3%
Beta
0.23

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Johnson & Johnson is currently in a long term uptrend where the price is trading 7.3% above its 200 day moving average.

From a valuation standpoint, the stock is 99.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.2.

Johnson & Johnson's total revenue rose by 8.3% to $22B since the same quarter in the previous year.

Its net income has dropped by 56.7% to $2B since the same quarter in the previous year.

Finally, its free cash flow grew by 36.6% to $7B since the same quarter in the previous year.

Based on the above factors, Johnson & Johnson gets an overall score of 4/5.